Clinical Trial

Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease

Study acronym: IMPACT
Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The purpose of this research study is to test the safety, tolerability, and effectiveness of the capsules that contain bacteria from healthy individuals when used to treat alcohol craving and drinking.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-11-30 -> 2027-05 2026-07-15
minor Completion pushed: 2026-12-30 -> 2027-11 2026-07-15
Trial Details
NCT Number NCT05548452
Lead Sponsor Virginia Commonwealth University
Collaborators: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions Liver Disease; Alcohol-Related, Cirrhosis, Alcohol Use Disorder
Enrollment 80 participants
Start Date 2022-11-21
Primary Completion 2027-05 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2026-07-14